Total Liabilities: The total value of all possible claims against the corporation.
Xeris Biopharma Holdings, Inc. (XERS) had Total Liabilities of $421.64M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$92.10M |
|
$-31.10M |
|
$12.51M |
|
$79.59M |
|
$86.93M |
|
$5.17M |
|
$-36.27M |
|
$-31.10M |
|
$-31.10M |
|
$-31.10M |
|
$-31.10M |
|
$-31.10M |
|
$-31.10M |
|
$5.17M |
|
$9.29M |
|
172.82M |
|
172.82M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$274.76M |
|
$4.83M |
|
$137.15M |
|
$411.90M |
|
$189.57M |
|
$188.81M |
|
$232.07M |
|
|
Total Liabilities |
$421.64M |
$-9.73M |
|
$-115.25M |
|
$-9.73M |
|
173.59M |
|
| Cash Flow Statement Financials | |
$18.13M |
|
$-0.53M |
|
$-6.89M |
|
$115.06M |
|
$125.77M |
|
$10.71M |
|
$15.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
1.05 |
|
-25.95 |
|
86.41% |
|
5.62% |
|
5.62% |
|
-- |
|
-33.77% |
|
-33.77% |
|
$17.60M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.15 |
|
1.59 |
|
56.78 |
|
319.51% |
|
26.99% |
|
-7.55% |
|
-17.37% |
|
$-0.06 |
|
$0.10 |
|
$0.10 |
|